This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
Lenti-luciferase-P2A-Neo
catalog :
105621
citations: 18
Reference
Chaib S, L xf3 pez Dom xed nguez J, Lalinde Guti xe9 rrez M, Prats N, Marin I, Boix O, et al. The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nat Cancer. 2024;: pubmed publisher
Zhang J, Ye Z, Br xe4 utigam L, Chakraborty P, Luo Z, Culpepper J, et al. A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progression. J Biol Chem. 2023;299:104920 pubmed publisher
Chang Y, Jin G, Luo W, Luo Q, Jung J, Hummel S, et al. Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioact Mater. 2023;27:168-180 pubmed publisher
Swan S, Mehta N, Ilich E, Shen S, Wilkinson D, Anderson A, et al. IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma. Front Immunol. 2023;14:1085547 pubmed publisher
Sheng G, Gao Y, Ding Q, Zhang R, Wang T, Jing S, et al. P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization. J Transl Med. 2023;21:132 pubmed publisher
Juras P, Racioppi L, Mukherjee D, Artham S, Gao X, Akullian D Agostino L, et al. Increased CaMKK2 Expression Is an Adaptive Response That Maintains the Fitness of Tumor-Infiltrating Natural Killer Cells. Cancer Immunol Res. 2023;11:109-122 pubmed publisher
Dai T, Rosario S, Katsuta E, Sawant Dessai A, Paterson E, Novickis A, et al. Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence. Cell Rep. 2022;41:111756 pubmed publisher
Russell S, Lim F, Peters P, Wardell S, Whitaker R, Chang C, et al. Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer. Cancers (Basel). 2022;14: pubmed publisher
Nemudraia A, Nemudryi A, Buyukyoruk M, Scherffius A, Zahl T, Wiegand T, et al. Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic. Res Sq. 2022;: pubmed publisher
Ren Q, Khoo W, Corr A, Phan T, Croucher P, Stewart S. Gene expression predicts dormant metastatic breast cancer cell phenotype. Breast Cancer Res. 2022;24:10 pubmed publisher
Polyanskaya S, Moreno R, Lu B, Feng R, Yao Y, Irani S, et al. SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia. Cell Rep. 2022;38:110233 pubmed publisher
Wei Y, Huang Y, Skopelitis D, Iyer S, Costa A, Yang Z, et al. SLC5A3-dependent myo-inositol auxotrophy in acute myeloid leukemia. Cancer Discov. 2021;: pubmed publisher
Feng W, Cao Z, Lim P, Zhao H, Luo H, Mao N, et al. Rapid interrogation of cancer cell of origin through CRISPR editing. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
Yang Z, Wu X, Wei Y, Polyanskaya S, Iyer S, Jung M, et al. Transcriptional silencing of ALDH2 confers a dependency on Fanconi anemia proteins in acute myeloid leukemia. Cancer Discov. 2021;: pubmed publisher
Kretschmer M, Kadlubowska P, Hoffmann D, Schwalbe B, Auerswald H, Schreiber M. Zikavirus prME Envelope Pseudotyped Human Immunodeficiency Virus Type-1 as a Novel Tool for Glioblastoma-Directed Virotherapy. Cancers (Basel). 2020;12: pubmed publisher
Lu B, Klingbeil O, Tarumoto Y, Somerville T, Huang Y, Wei Y, et al. A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence. Cancer Cell. 2018;34:970-981.e8 pubmed publisher
Somerville T, Xu Y, Miyabayashi K, Tiriac H, Cleary C, Maia Silva D, et al. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Cell Rep. 2018;25:1741-1755.e7 pubmed publisher
Xu Y, Milazzo J, Somerville T, Tarumoto Y, Huang Y, Ostrander E, et al. A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Cancer Cell. 2018;33:13-28.e8 pubmed publisher
product information
Catalog Number :
105621
Product Name :
Lenti-luciferase-P2A-Neo
article :
doi10.1016/j.ccell.2017.12.002
id28192474
pubmed_id29316427
bacterial resistance :
Ampicillin
cloning :
backboneLentiV
backbone_mutation
backbone_origin
backbone_size
promoter
sequencing_primer_3
sequencing_primer_5
vector_types
Mammalian Expression
Lentiviral
Luciferase
growth strain :
3rd generation lentiviral plasmid for expression of luciferase with Neo resistance
origin :
37
pi :
alt_names
cloning
clone_methodLigation Independent Cloning
cloning_site_3
cloning_site_5
promoterEFS
sequencing_primer_3
sequencing_primer_5AACCGGTGCCTAGAGAAGGT
site_3_destroyed
site_5_destroyed
entrez_gene
genbank_ids
mutation
nameLuciferase
shRNA_sequence
size
species
32644
Other
tags
resistance markers :
2374
tags :
Unknown
terms :
Neomycin (select with G418)
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
info@addgene.org
https://www.addgene.org
617.225.9000
headquarters: USA